124 related articles for article (PubMed ID: 15154867)
1. Study of plasma exchange for liver failure: beneficial and harmful effects.
Abe T; Kobata H; Hanba Y; Kitabata Y; Narukawa N; Hasegawa H; Abe T; Fukagawa M
Ther Apher Dial; 2004 Jun; 8(3):180-4. PubMed ID: 15154867
[TBL] [Abstract][Full Text] [Related]
2. Comparison of citrate anticoagulation during plasma exchange with different replacement solutions.
Antonic M; Gubensek J; Buturović-Ponikvar J; Ponikvar R
Ther Apher Dial; 2009 Aug; 13(4):322-6. PubMed ID: 19695068
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of combining plasma exchange and continuous hemodiafiltration in patients with postoperative liver failure.
Yonekawa C; Nakae H; Tajimi K; Asanuma Y
Artif Organs; 2005 Apr; 29(4):324-8. PubMed ID: 15787627
[TBL] [Abstract][Full Text] [Related]
4. Citrate anticoagulation during plasma exchange in a patient with thrombotic thrombocytopenic purpura: short heparin-free hemodialysis helps to attenuate citrate load.
Buturović-Ponikvar J; Pernat AM; Ponikvar R
Ther Apher Dial; 2005 Jun; 9(3):258-61. PubMed ID: 15967002
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of curative effect of low flow rate plasma exchange combined with hemofiltration for treatment of liver failure].
Yang YF; Huang P; Zhang N; Gai XD; Feng XN; Zhong YD; Wang LR; Yang YJ; Zhao W
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Feb; 21(2):111-3. PubMed ID: 19220966
[TBL] [Abstract][Full Text] [Related]
8. Falsely low calcium measurements after high volume plasma exchange in a patient with liver failure.
Miller JP; Mintz PD
Transfus Sci; 1994 Sep; 15(3):299-302. PubMed ID: 10161259
[TBL] [Abstract][Full Text] [Related]
9. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
10. Plasma exchange-based plasma recycling dialysis system as a potential platform for artificial liver support.
Nishimura A; Umehara Y; Umehara M; Hakamada K; Narumi S; Toyoki Y; Yoshihara S; Sasaki M
Artif Organs; 2006 Aug; 30(8):629-33. PubMed ID: 16911318
[TBL] [Abstract][Full Text] [Related]
11. Elevated hepatocyte growth factor levels at the beginning of high-flux hemodialysis are due to heparin administration.
Christidou F; Bamichas G; Galaktidou G; Fragidis S; Gionanlis L; Frangia T; Bischiniotis T; Sombolos K
Ren Fail; 2008; 30(9):861-4. PubMed ID: 18925524
[TBL] [Abstract][Full Text] [Related]
12. Correction of metabolic acidosis on serum albumin and protein catabolism in hemodialysis patients.
Movilli E; Viola BF; Camerini C; Mazzola G; Cancarini GC
J Ren Nutr; 2009 Mar; 19(2):172-7. PubMed ID: 19218045
[TBL] [Abstract][Full Text] [Related]
13. Plasma insulin is removed by hemodialysis: evaluation of the relation between plasma insulin and glucose by using a dialysate with or without glucose.
Abe M; Kaizu K; Matsumoto K
Ther Apher Dial; 2007 Aug; 11(4):280-7. PubMed ID: 17661834
[TBL] [Abstract][Full Text] [Related]
14. Hyperbaric oxygenation, plasma exchange, and hemodialysis for treatment of acute liver failure in a 3-year-old child.
Ponikvar R; Buturović J; Cizman M; Mekjavić I; Kandus A; Premru V; Urbancic A; Zakotnik B; Bren A; Ivanovich P
Artif Organs; 1998 Nov; 22(11):952-7. PubMed ID: 9821529
[TBL] [Abstract][Full Text] [Related]
15. Calcium exposure and removal in chronic hemodialysis patients.
Sigrist M; McIntyre CW
J Ren Nutr; 2006 Jan; 16(1):41-6. PubMed ID: 16414440
[TBL] [Abstract][Full Text] [Related]
16. Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study.
Schultheiß C; Saugel B; Phillip V; Thies P; Noe S; Mayr U; Haller B; Einwächter H; Schmid RM; Huber W
Crit Care; 2012 Aug; 16(4):R162. PubMed ID: 22913794
[TBL] [Abstract][Full Text] [Related]
17. [Acetate-free on-line PHF: how to improve hyperacetatemia and haemodynamic tolerance].
Coll E; Pérez-García R; Martín de Francisco AL; Galcerán J; García-Osuna R; Martín-Malo A; Martínez-Castelao A; Sánchez B; Llopis R; Alvarez de Lara MA
Nefrologia; 2009; 29(2):156-62. PubMed ID: 19396322
[TBL] [Abstract][Full Text] [Related]
18. Citrate anticoagulation for single-needle hemodialysis: safety and efficacy.
Buturović-Ponikvar J; Gubensek J; Ponikvar R
Ther Apher Dial; 2005 Jun; 9(3):237-40. PubMed ID: 15966997
[TBL] [Abstract][Full Text] [Related]
19. Alteration of heart rate variability parameters in nondiabetic hemodialysis patients.
Tong YQ; Hou HM
Am J Nephrol; 2007; 27(1):63-9. PubMed ID: 17259695
[TBL] [Abstract][Full Text] [Related]
20. Variability of acid-base status in acetate-free biofiltration 84% versus bicarbonate dialysis.
Harzallah K; Hichri N; Mazigh C; Tagorti M; Hmida A; Hmida J
Saudi J Kidney Dis Transpl; 2008 Mar; 19(2):215-21. PubMed ID: 18310870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
